Last reviewed · How we verify

Asthma Controller Therapies — Competitive Intelligence Brief

Asthma Controller Therapies (Asthma Controller Therapies) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Respiratory/Pulmonology.

phase 3 Respiratory/Pulmonology Small molecule Live · refreshed every 30 min

Target snapshot

Asthma Controller Therapies (Asthma Controller Therapies) — Sanofi. Asthma controller therapies work by reducing airway inflammation and preventing asthma symptoms through various mechanisms including corticosteroid action, leukotriene modulation, or biologic targeting of inflammatory pathways.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Asthma Controller Therapies TARGET Asthma Controller Therapies Sanofi phase 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Asthma Controller Therapies — Competitive Intelligence Brief. https://druglandscape.com/ci/asthma-controller-therapies. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: